Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

DeVry Q3 Profit Falls

RELATED NEWS
Trade DV now with 
4/24/2012 7:13 PM ET

Educational services provider DeVry Inc (DV: Quote) reported third-quarter net income attributable to the company of $67.1 million or $1.00 per share, down from $92.9 or $1.32 per share.

On average, 14 analysts polled by Thomson Reuters expected earnings of $0.99 per share for the quarter. Analysts' estimates typically exclude special items.

Revenue for the quarter declined 4 percent to $540.8 million from $562.7 million a year ago.

Analysts expected revenues of $529.45 million for the quarter.

Click here to receive FREE breaking news email alerts for DeVry Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After moving sharply lower at the start of trading on Thursday, stocks showed a substantial recovery attempt over the course of the trading day. The rebound came as upbeat housing data helped offset worries about the Federal Reserve. The major averages climbed well off their worst levels of the day but still ended the session in the red. President Barack Obama delivered a highly-anticipated speech on his administration's evolving counterterrorism policies on Thursday, suggesting that the U.S. needs to move away from a "boundless global war on terror." More than a decade after the 9/11 attacks, Obama argued that the terrorist threat has shifted and evolved. In another upbeat sign for the U.S. housing market, the Commerce Department released a report on Thursday showing that new home sales came in well above economist estimates in the month of April. The report showed that new home sales climbed 2.3 percent to a seasonally adjusted annual rate of 454,000 in April from the revised March rate of 444,000.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.